Continuous Bioprocessing Market is segmented by Product (Filtration, Chromatography, Centrifuges, Consumables), Application (Commercial {Vaccines, Monoclonal Antibodies}, R&D), End User (Pharmaceuticals, Biotechnology, CROs), and Geography.

The Continuous Bioprocessing Market is expected to grow at a CAGR of 23.0% from 2021 reaching a market size value of USD 429.12 million by 2028.

Continuous Bioprocessing is an activity that entails manufacturing of biopharmaceuticals involving a continuous unit operations which are physically adjoining with lesser holding volume. The growth of this market can be attributed to factors such as, the increasing demand for biopharmaceuticals, innovations in continuous bioprocessing, product introductions in the field of bioprocessing, and numerous support towards the application of biopharmaceuticals globally.

COVID-19 Impact Assessment

There is a negative impact brought upon by the pandemic because of the lock downs and implemented protocols which may have disrupted the supply chain, distribution and operations in facilities of prominent companies. This can be considered a big set back in the growth of the continuous bioprocessing market because if manufacturing and distribution of supply of raw materials and equipment relative to the procedure are affected, production and sales to end users will also be negatively affected making it challenging for these companies to meet demands.

There is also a disruption of the supply chain, and has affected distribution and manufacturing in facilities in prominent companies across the globe. This can be considered a big set back in the growth of the market because if manufacturing and distribution of products and equipment are affected, production and sales will also be negatively affected making it challenging for these companies to meet demands of end users. Suppliers of continuous bioprocessing equipment also had the challenge of exporting and importing raw materials for processing of their products since there have been borders restriction resulting to fewer sales and availability of products.

On a positive note, the pandemic has brought some significant boost in the market’s growth. Industries are being challenged on how will they come up with the best business strategies in the face of a pandemic. The bioprocessing industry made partnerships and collaborations with other emerging markets to prioritize and accelerate research and development as well as optimal planning on how to boost production processes. The need for volume manufacturing like that of the continuous processing is projected to cause a significant hike in the market growth.

Key Findings in the Global Continuous Bioprocessing Market

In terms of product, the market is further segmented into filtration systems & consumables; chromatography systems & consumables; bioreactors; sterilizers; centrifuges; incubators & shakers; mixing systems; cell culture media, buffers, and reagents; and other products. However, the filtration systems and consumables segment is expected to have the largest share accounted for in the market in 2020. the factors driving the growth of this segment are, increasing demand for high-quality standards in biopharma manufacturing especially in filter operations and innovations on filtration technologies by filter manufacturers for continuous bioprocessing to accomplish both purification and separation by using a combination of physical removal ability and size omission.

In terms of application, during the forecast period, the research & development segment is expected to grow at the highest CAGR. The growth drivers are, increasing focus on research and development of vaccines as well as appropriate COVID-19 therapies, and thriving connection of mAB manufacturing with regard to treatment of various diseases.

In terms of end user, the pharmaceutical and biotechnology companies segment leads the market. There is a change done by pharmacy and biopharma manufacturers from batch to continuous processing; this in turn caused significant benefits to such manufacturers because it is cost-effective, fewer infrastructure demand, less in space, investment, staff while considering that it manufacture the products all at the same time thus, making it time-saving.

Regional Market Analysis

In terms of region, the continuous bioprocessing market is further segmented into North America, Europe, APAC, Latin America, and the Middle East & Africa. However, Asia Pacific is projected as the fastest growing regional market out of all. This growth is mainly attributed to the emergence of biopharmaceuticals in Asian countries gradually, expansions in CDMO, innovations in bioprocessing technologies, prevalence of partnerships and collaborations with major market players.

Key Players: Share and Competition

Based on an extensive assessment, these major key players in the Continuous Bioprocessing Market have a competitive landscape and utilizing key strategic developments to lead the industry over the past years until now. These companies are, 3M (U.S.), Cytiva (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), Sartorius AG (Germany), Repligen Corporation (U.S.), Eppendorf AG (Germany), Applikon Biotechnology (Netherlands), Pall Corporation (U.S.), and Bionet (Spain).

Report Highlights
• Historical data available (as per request)
• Estimation/projections/forecast for revenue and unit sales (2021 – 2028)
• Data breakdown for every market segment (2021 – 2028)
• Gross margin and profitability analysis of companies
• Price analysis of each product type
• Business trend and expansion analysis
• Import and export analysis
• Competition analysis/market share
• Supply chain analysis
• Client list and case studies
• Market entry strategy

Industry Segmentation and Revenue Breakdown

Product Analysis (Revenue, USD Million, 2021 - 2028)

• Filtration Systems and Consumables
• Chromatography Systems and Consumables
• Bioreactors
• Sterilizers
• Centrifuges
• Incubators and Shakers
• Mixing Systems
• Cell Culture Media, Buffers, and Reagents
• Other instruments and consumables

Application Analysis (Revenue, USD Million, 2021 - 2028)

• Commercial
• Vaccines
• mAb production
• Recombinant Protein Production
• Cell and Gene Therapy Production
• R&D

End User Analysis (Revenue, USD Million, 2021 - 2028)

• Pharmaceutical and Biotechnology Companies
• Contract Development and Manufacturing Organizations and Contract Research Organizations
• Academic and Research Institutes

Region Analysis (Revenue, USD Million, 2020 – 2028)

• United States
• Canada
• Mexico
• France
• Germany
• Italy
• Spain
• United Kingdom
• Russia
• China
• India
• Philippines
• Malaysia
• Australia
• Austria
• South Korea
• UAE
• Qatar
• Saudi Arabia
• Japan
• Africa
• Rest of World

Available Versions:
• United States Continuous Bioprocessing Industry Research Report
• Europe Continuous Bioprocessing Industry Research Report
• Asia Pacific Continuous Bioprocessing Industry Research Report

Need report on this market for specific region or Country? Or need a customized report as per your need? Want to know discounts as available?

Email US

David Correa

david@marketdecipher.com

Or Fill the form below "Sample Request Form" with your queries in message box.